Wells Fargo & Company Rockwell Medical, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 590 shares of RMTI stock, worth $2,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
590
Previous 813
27.43%
Holding current value
$2,295
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RMTI
# of Institutions
44Shares Held
6.44MCall Options Held
11KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY3.22MShares$12.5 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.12MShares$4.35 Million0.0% of portfolio
-
Perkins Capital Management Inc350KShares$1.36 Million1.37% of portfolio
-
Geode Capital Management, LLC Boston, MA305KShares$1.19 Million0.0% of portfolio
-
Richmond Brothers, Inc. Jackson, MI277KShares$1.08 Million0.99% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $41.5M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...